Fig 1.
PRISMA flow.
Table 1.
Active treatment (isolated hypotension without any clinical or biochemical signs of poor perfusion) compared to restrictive treatment (no treatment of isolated hypotension or treatment of hypotension with clinical or biochemical signs of poor perfusion) in preterm neonates born at less than 37 weeks' gestation in the first week of postnatal life.
Fig 2.
Forest plot depicting the effect estimates from randomized controlled trials and non-randomized controlled trials for the various outcomes.